Skip to main content

Drug Interactions between maprotiline and Romazicon

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

maprotiline flumazenil

Applies to: maprotiline and Romazicon (flumazenil)

GENERALLY AVOID: Severe adverse effects, including fatalities, have been reported following the administration of flumazenil to multiple-drug-overdose patients who have taken large quantities of tricyclic antidepressants. The effects have included seizures and arrhythmias (including ventricular tachycardia). The mechanism of this interaction may be related to a decrease in the protective antiseizure effects of benzodiazepines that patients may have taken concomitantly with overdoses of tricyclic antidepressants.

MANAGEMENT: Administration of flumazenil should be avoided in patients who are known or suspected to have received overdoses of tricyclic antidepressants.

References (6)
  1. Lheureux P, Vrankx M, Askenasi R (1991) "Administration of flumazenil." Ann Emerg Med, 20, p. 592-3
  2. Marchant B, Wray R, Leach A, Nama M (1989) "Flumazenil causing convulsions and ventricular tachycardia." BMJ, 299, p. 860
  3. Bodenham AR (1989) "Death after flumazenil." BMJ, 299, p. 457
  4. Mordel A, Winkler E, Almog S, Tirosh M, Ezra D (1992) "Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose." Crit Care Med, 20, p. 1733-4
  5. (1992) "Flumazenil." Med Lett Drugs Ther, 34, p. 66-8
  6. Geller E, Crome P, Schaller MD, Marchant B, Ectors M, Scollo-Lavizzari G (1991) "Risks and benefits of therapy with flumazenil (Anexate) in mixed drug intoxications." Eur Neurol, 31, p. 241-50

Drug and food/lifestyle interactions

Moderate

maprotiline food/lifestyle

Applies to: maprotiline

GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.

MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.

References (4)
  1. Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
  2. Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
  3. (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
  4. (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer